T1	Intervention 719 757	randomised to SFC or FP/M for 12 weeks
T2	Intervention 481 685	effects of salmeterol plus fluticasone propionate (FP) (Seretide; SFC) and FP plus montelukast (FP/M) on sputum inflammatory markers, airway responsiveness, lung function, and symptoms in adult asthmatics
